|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 114.87 AUD | -2.36% |
|
-1.25% | -33.47% |
| 26/06 | European Regulator Calls for Amgen's Tavneos to Have Authorization Revoked -- Update | DJ |
| 25/06 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| Market Cap | 3.8TCr 3.33TCr 3.07TCr 2.87TCr 5.39TCr 3,58300Cr 5.5TCr 37TCr 14TCr 1,77100Cr 14TCr 14TCr 6,14100Cr | P/E 2026 * |
-51.1x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4.68TCr 4.11TCr 3.78TCr 3.54TCr 6.64TCr 4,41800Cr 6.78TCr 45TCr 18TCr 2,18300Cr 18TCr 17TCr 7,57100Cr | EV / Sales 2026 * |
3.04x | EV / Sales 2027 * | 2.94x |
| Free-Float |
99.3% | Yield 2026 * |
3.59% | Yield 2027 * | 3.7% |
Last Transcript: CSL Limited
| 1 day | -2.36% | ||
| 1 week | -1.25% | ||
| Current month | +18.90% | ||
| 1 month | +15.73% | ||
| 3 months | -19.78% | ||
| 6 months | -33.01% | ||
| Current year | -33.47% |
| 1 week | 110.89 |  | 118.88 |
| 1 month | 90 | | 118.88 |
| Current year | 90 | | 184.62 |
| 1 year | 90 | | 275.79 |
| 3 years | 90 | | 313.55 |
| 5 years | 90 | | 319.78 |
| 10 years | 90 | | 342.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gordon Naylor
CEO | Chief Executive Officer | 63 | 11/02/2026 |
Ken Lim
DFI | Director of Finance/CFO | 52 | 07/10/2025 |
Mark Hill
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/10/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 17/10/2018 | |
Marie McDonald
BRD | Director/Board Member | 70 | 14/08/2013 |
Megan Clark
BRD | Director/Board Member | 68 | 16/02/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/06 | Buy | Director | 1,036 | 0.0002% | ||
| 26/05 | Buy | Chief Executive Officer | 1,100 | 0.0002% | ||
| 26/05 | Buy | Chief Executive Officer | 1,100 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.36% | -1.25% | -50.98% | -58.84% | 3.8TCr | |
| +2.06% | +3.76% | +21.48% | -11.62% | 6.44TCr | |
| +0.74% | +3.52% | +51.88% | +225.16% | 5.61TCr | |
| -3.10% | +34.30% | +34.30% | +34.30% | 4.05TCr | |
| +6.97% | +9.89% | +71.34% | -23.65% | 3.19TCr | |
| +12.59% | +5.18% | +147.68% | -44.25% | 2.67TCr | |
| +5.78% | +15.81% | +66.37% | +84.42% | 2.27TCr | |
| -1.25% | -1.31% | -2.84% | +151.34% | 1.67TCr | |
| -0.81% | +5.91% | +63.81% | +125.65% | 1.66TCr | |
| +0.79% | +5.99% | +56.58% | +331.18% | 1.38TCr | |
| Average | +2.14% | +4.49% | +45.96% | +81.37% | 3.27TCr | |
| Weighted average by Cap. | +1.91% | +4.19% | +40.52% | +61.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.54TCr 1.35TCr 1.24TCr 1.16TCr 2.18TCr 1,45200Cr 2.23TCr 15TCr 5.78TCr 72TCr 5.78TCr 5.65TCr 2,48800Cr | 1.57TCr 1.37TCr 1.27TCr 1.19TCr 2.22TCr 1,47800Cr 2.27TCr 15TCr 5.89TCr 73TCr 5.88TCr 5.76TCr 2,53300Cr |
| Net income | -89Cr -78Cr -72Cr -68Cr -126.76Cr -8.43TCr -129.39Cr -867.84Cr -335.81Cr -4.17TCr -335.47Cr -328.14Cr -14TCr | 118.73Cr 104.1Cr 96Cr 90Cr 168.46Cr 11TCr 171.96Cr 1.15TCr 446.28Cr 5.54TCr 445.83Cr 436.1Cr 19TCr |
| Net Debt | 884.73Cr 775.73Cr 715.04Cr 669.43Cr 1.26TCr 83TCr 1.28TCr 8.59TCr 3.33TCr 41TCr 3.32TCr 3.25TCr 1,43000Cr | 806.96Cr 707.54Cr 652.19Cr 610.58Cr 1.14TCr 76TCr 1.17TCr 7.84TCr 3.03TCr 38TCr 3.03TCr 2.96TCr 1,30500Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/26/26 | A$114.87 | -2.36% | 23,08,629 |
| 25/26/25 | A$117.65 | +2.31% | 20,66,413 |
| 24/26/24 | A$114.99 | +2.63% | 18,26,320 |
| 23/26/23 | A$112.04 | -0.74% | 16,83,171 |
| 22/26/22 | A$112.88 | -2.96% | 26,12,502 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CSL Stock
Select your edition
All financial news and data tailored to specific country editions
